Literature DB >> 21839663

Metabolic and monogenic causes of seizures in neonates and young infants.

Johan L K Van Hove1, Naomi J Lohr.   

Abstract

Seizures in neonates or young infants present a frequent diagnostic challenge. After exclusion of acquired causes, disturbances of the internal homeostasis and brain malformations, the physician must evaluate for inborn errors of metabolism and for other non-malformative genetic disorders as the cause of seizures. The metabolic causes can be categorized into disorders of neurotransmitter metabolism, disorders of energy production, and synthetic or catabolic disorders associated with brain malformation, dysfunction and degeneration. Other genetic conditions involve channelopathies, and disorders resulting in abnormal growth, differentiation and formation of neuronal populations. These conditions are important given their potential for treatment and the risk for recurrence in the family. In this paper, we will succinctly review the metabolic and genetic non-malformative causes of seizures in neonates and infants less than 6 months of age. We will then provide differential diagnostic clues and a practical paradigm for their evaluation. Copyright Â
© 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21839663     DOI: 10.1016/j.ymgme.2011.04.020

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  9 in total

1.  Profile of neonatal epilepsies: Characteristics of a prospective US cohort.

Authors:  Renée A Shellhaas; Courtney J Wusthoff; Tammy N Tsuchida; Hannah C Glass; Catherine J Chu; Shavonne L Massey; Janet S Soul; Natrujee Wiwattanadittakun; Nicholas S Abend; Maria Roberta Cilio
Journal:  Neurology       Date:  2017-07-21       Impact factor: 9.910

2.  A population-based cost-effectiveness study of early genetic testing in severe epilepsies of infancy.

Authors:  Katherine B Howell; Stefanie Eggers; Kim Dalziel; Jessica Riseley; Simone Mandelstam; Candace T Myers; Jacinta M McMahon; Amy Schneider; Gemma L Carvill; Heather C Mefford; Ingrid E Scheffer; A Simon Harvey
Journal:  Epilepsia       Date:  2018-05-11       Impact factor: 5.864

3.  Normal Neurodevelopmental Outcomes in PNPO Deficiency: A Case Series and Literature Review.

Authors:  J Hatch; D Coman; P Clayton; P Mills; S Calvert; R I Webster; Kate Riney
Journal:  JIMD Rep       Date:  2015-08-25

Review 4.  Contemporary scope of inborn errors of metabolism involving epilepsy or seizures.

Authors:  Birutė Tumienė; Borut Peterlin; Aleš Maver; Algirdas Utkus
Journal:  Metab Brain Dis       Date:  2018-07-13       Impact factor: 3.584

Review 5.  Neonatal neuroimaging findings in inborn errors of metabolism.

Authors:  Andrea Poretti; Susan I Blaser; Maarten H Lequin; Ali Fatemi; Avner Meoded; Frances J Northington; Eugen Boltshauser; Thierry A G M Huisman
Journal:  J Magn Reson Imaging       Date:  2012-05-07       Impact factor: 4.813

Review 6.  Epileptic Encephalopathy in Childhood: A Stepwise Approach for Identification of Underlying Genetic Causes.

Authors:  Jaina Patel; Saadet Mercimek-Mahmutoglu
Journal:  Indian J Pediatr       Date:  2016-01-29       Impact factor: 1.967

Review 7.  Metabolic etiologies in West syndrome.

Authors:  Seda Salar; Solomon L Moshé; Aristea S Galanopoulou
Journal:  Epilepsia Open       Date:  2018-03-14

Review 8.  Neonatal Seizures: Impact on Neurodevelopmental Outcomes.

Authors:  Seok Kyu Kang; Shilpa D Kadam
Journal:  Front Pediatr       Date:  2015-11-23       Impact factor: 3.418

Review 9.  Inborn Errors of Metabolism and Epilepsy: Current Understanding, Diagnosis, and Treatment Approaches.

Authors:  Suvasini Sharma; Asuri N Prasad
Journal:  Int J Mol Sci       Date:  2017-07-02       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.